Valuein

Overview

METTLER TOLEDO INTERNATIONAL INC/

MTDNYSEHealth CareLaboratory Analytical InstrumentsCIK 0001037646Large-cap benchmark

Latest 10-K: FY2025, filed Feb 6, 2026 · Open the 10-K (Inline XBRL) ↗

Revenue
$4.03B
4.0%YoYup from FY2024
TotalRevenue
Gross profit
$2.39B
2.8%YoYup from FY2024
GrossProfit
Net income
$0.87B
0.7%YoYup from FY2024
NetIncome
Diluted EPS
$42.05
3.9%YoYup from FY2024
EPSDiluted
Diluted shares
20.7M
3.0%YoYdown from FY2024
WeightedAvgSharesDiluted

At a glance

Growth

  • METTLER TOLEDO INTERNATIONAL INC/ reported revenue of $4.03B for fiscal 2025, up 4.0% from fiscal 2024.
  • Revenue grew faster than the median S&P 500 member in 1 of the last 5 fiscal years.

Profitability

  • Net margin was 21.6%, against a median of 12.8% across S&P 500 members for the same fiscal year.

Per share

  • Diluted EPS was $42.05, up 3.9% from the prior year.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Revenue
$4.03B4.0%up
Benchmark median 6.4%
$3.87B2.2%up
Benchmark median 4.5%
$3.79B3.4%down
Benchmark median 4.8%
$3.92B5.4%up
Benchmark median 10.3%
$3.72B20.5%up
Benchmark median 13.8%
2.0%
Benchmark median 6.6%
Gross Profit
Median of 315 / 498
$2.39B2.8%up
Benchmark median 6.8%
$2.33B3.8%up
Benchmark median 5.5%
$2.24B2.9%down
Benchmark median 5.2%
$2.31B6.3%up
Benchmark median 8.3%
$2.17B20.6%up
Benchmark median 15.7%
2.4%
Benchmark median 6.2%
Operating Income
Median of 373 / 498
—
—
—
—
—
—
Benchmark median 7.2%
Net Income
$869.19M0.7%up
Benchmark median 4.8%
$863.14M9.4%up
Benchmark median 5.7%
$788.78M9.6%down
Benchmark median 1.9%
$872.50M13.5%up
Benchmark median 1.3%
$768.99M27.6%up
Benchmark median 33.9%
3.1%
Benchmark median 4.1%
EPS (Diluted)
$42.053.9%up
Benchmark median 6.2%
$40.4812.8%up
Benchmark median 7.9%
$35.906.5%down
Benchmark median 1.9%
$38.4117.2%up
Benchmark median 1.5%
$32.7831.6%up
Benchmark median 34.8%
6.4%
Benchmark median 5.6%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Total Assets
$3.71B14.6%up
Benchmark median 5.6%
$3.24B3.4%down
Benchmark median 3.4%
$3.36B3.9%down
Benchmark median 4.1%
$3.49B5.0%up
Benchmark median 2.2%
$3.33B18.2%up
Benchmark median 6.7%
2.8%
Benchmark median 4.7%
Total Liabilities
Median of 357 / 498
$3.74B11.0%up
Benchmark median 6.4%
$3.37B4.0%down
Benchmark median 1.9%
$3.51B1.1%up
Benchmark median 2.9%
$3.47B9.9%up
Benchmark median 2.0%
$3.16B24.6%up
Benchmark median 5.2%
4.3%
Benchmark median 4.4%
Stockholders' Equity
negative: -$23.64Mn/m
Benchmark median 6.8%
negative: -$126.89Mn/m
Benchmark median 5.4%
negative: -$149.94M704.8%down
Benchmark median 7.3%
$24.79M85.5%down
Benchmark median 2.5%
$171.42M39.4%down
Benchmark median 9.0%
n/m
Benchmark median 6.1%
Cash & Equivalents
—
—
$69.81M27.3%down
Benchmark median 6.7%
$95.97M2.6%down
Benchmark median -8.6%
$98.56M4.6%up
Benchmark median -2.9%
—
Benchmark median 2.0%
Total Debt
$2.15B6.9%up
Benchmark median 2.1%
$2.01B3.2%down
Benchmark median 0.2%
$2.08B3.3%up
Benchmark median 0.3%
$2.01B19.8%up
Benchmark median 0.1%
$1.68B26.0%up
Benchmark median -0.1%
6.4%
Benchmark median 4.3%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Operating Cash Flow
$955.77M1.3%down
Benchmark median 6.3%
$968.35M0.3%up
Benchmark median 4.8%
$965.87M12.4%up
Benchmark median 9.9%
$859.07M5.5%down
Benchmark median -0.7%
$908.83M25.4%up
Benchmark median 10.7%
1.3%
Benchmark median 7.0%
Capital Expenditures
$107.12M3.1%up
Benchmark median 5.4%
$103.90M1.4%down
Benchmark median 2.8%
$105.32M13.1%down
Benchmark median 11.3%
$121.24M12.7%up
Benchmark median 14.0%
$107.58M16.3%up
Benchmark median 8.1%
-0.1%
Benchmark median 9.0%
Free Cash Flow
Median of 378 / 498
$848.65M1.8%down
Benchmark median 7.3%
$864.45M0.5%up
Benchmark median 6.1%
$860.55M16.6%up
Benchmark median 8.8%
$737.83M7.9%down
Benchmark median -11.3%
$801.25M26.7%up
Benchmark median 10.2%
1.4%
Benchmark median 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

3.0%

Wall Street

on net earnings

FY2024 3.3%

2.9%

Value investor

on free cash flow

FY2024 3.3%

Gap −0.1 pts: Value-investor figure 0.1 points lower

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 33.2×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on MTD yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on MTD and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/MTD

APA-style text
Valuein. (2026, October 31). METTLER TOLEDO INTERNATIONAL INC/ (MTD) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/MTD
BibTeX
@misc{valuein_mtd_2026,
  author = {{Valuein}},
  title = {METTLER TOLEDO INTERNATIONAL INC/ (MTD) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/MTD}},
  note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed Feb 6, 2026 · accession 0001037646-26-000011

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.